<?xml version="1.0" encoding="utf-8"?>
<rr:ResultsReport>
	<rr:ResultsPayload>
		<FinalReport>
			<Sample>
				<FM_Id>AA -22-02113</FM_Id>
				<SampleId></SampleId>
				<BlockId>S111-99226_(PT22023)</BlockId>
				<TRFNumber></TRFNumber>
				<TestType></TestType>
				<SpecFormat>Pancreas  Type</SpecFormat>
				<ReceivedDate>Apr 22, 2022</ReceivedDate>
			</Sample>
			<PMI>
				<ReportId></ReportId>
				<MRN>38194115</MRN>
				<FullName>陳翠珠</FullName>
				<FirstName></FirstName>
				<LastName></LastName>
				<SubmittedDiagnosis>Pancreatic cancer</SubmittedDiagnosis>
				<Gender>Female</Gender>
				<DOB>Jun 04, 1959</DOB>
				<OrderingMD>周德盈醫師 /姜乃榕醫師</OrderingMD>
				<OrderingMDId></OrderingMDId>
				<Pathologist></Pathologist>
				<CopiedPhysician1></CopiedPhysician1>
				<MedFacilName>臺北榮總</MedFacilName>
				<MedFacilID></MedFacilID>
				<SpecSite></SpecSite>
				<CollDate></CollDate>
				<ReceivedDate></ReceivedDate>
				<CountryOfOrigin></CountryOfOrigin>
			</PMI>
		</FinalReport>
		<variant-report>
			<short_variants>
				<short_variant>
					<cds_effect>c.1799_1801del</cds_effect>
					<depth>1336</depth>
					<gene>BRAF</gene>
					<percent_reads>31.9%</percent_reads>
					<protein_effect>V600_K601delinsE</protein_effect>
					<transcript>NM_004333</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>42.9%</depth>
					<gene>TP53</gene>
					<percent_reads>COSM44295</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.993+1G&gt;A</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1764C&gt;G</cds_effect>
					<depth>339</depth>
					<gene>DOT1L</gene>
					<percent_reads>75.5%</percent_reads>
					<protein_effect>D588E</protein_effect>
					<transcript>NM_032482</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1123G&gt;T</cds_effect>
					<depth>440</depth>
					<gene>EPHA2</gene>
					<percent_reads>6.1%</percent_reads>
					<protein_effect>E375*</protein_effect>
					<transcript>NM_004431</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1404G&gt;T</cds_effect>
					<depth>346</depth>
					<gene>EPHA2</gene>
					<percent_reads>7.5%</percent_reads>
					<protein_effect>K468N</protein_effect>
					<transcript>NM_004431</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1401G&gt;A</cds_effect>
					<depth>346</depth>
					<gene>EPHA2</gene>
					<percent_reads>7.5%</percent_reads>
					<protein_effect>W467*</protein_effect>
					<transcript>NM_004431</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.1447G&gt;A</cds_effect>
					<depth>400</depth>
					<gene>ERBB2</gene>
					<percent_reads>53.5%</percent_reads>
					<protein_effect>D483N</protein_effect>
					<transcript>NM_004448</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>49.4%</depth>
					<gene>FANCL</gene>
					<percent_reads>-</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.155+7T&gt;C</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.10930_10931delinsAT</cds_effect>
					<depth>1212</depth>
					<gene>FAT1</gene>
					<percent_reads>51.4%</percent_reads>
					<protein_effect>A3644M</protein_effect>
					<transcript>NM_005245</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.12695A&gt;G</cds_effect>
					<depth>747</depth>
					<gene>FAT1</gene>
					<percent_reads>54.1%</percent_reads>
					<protein_effect>Y4232C</protein_effect>
					<transcript>NM_005245</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.3289C&gt;T</cds_effect>
					<depth>168</depth>
					<gene>IRS2</gene>
					<percent_reads>51.2%</percent_reads>
					<protein_effect>R1097C</protein_effect>
					<transcript>NM_003749</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.10979G&gt;C</cds_effect>
					<depth>178</depth>
					<gene>KMT2D</gene>
					<percent_reads>50.0%</percent_reads>
					<protein_effect>G3660A</protein_effect>
					<transcript>NM_003482</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>c.3586G&gt;A</cds_effect>
					<depth>156</depth>
					<gene>NOTCH4</gene>
					<percent_reads>44.2%</percent_reads>
					<protein_effect>G1196R</protein_effect>
					<transcript>NM_004557</transcript>
				</short_variant>
				<short_variant>
					<cds_effect>-</cds_effect>
					<depth>-</depth>
					<gene>VEGFB</gene>
					<percent_reads>NM_003377</percent_reads>
					<protein_effect>Splice</protein_effect>
					<transcript>c.411</transcript>
				</short_variant>
			</short_variants>
			<copy_number_alterations>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>SMAD4</gene>
					<position>Chr18</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>STK11</gene>
					<position>Chr19</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>BAP1</gene>
					<position>Chr3</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>8</copy_number>
					<gene>FGFR1</gene>
					<position>Chr8</position>
					<type>Amplification</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>SMAD4</gene>
					<position>Chr18</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>STK11</gene>
					<position>Chr19</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>1</copy_number>
					<gene>BAP1</gene>
					<position>Chr3</position>
					<type>Heterozygous deletion</type>
				</copy_number_alteration>
				<copy_number_alteration>
					<copy_number>8</copy_number>
					<gene>FGFR1</gene>
					<position>Chr8</position>
					<type>Amplification</type>
				</copy_number_alteration>
			</copy_number_alterations>
			<rearrangements>
			</rearrangements>
			<biomarkers>
				<microsatellite_instability>
					<status>Microsatellite stable (MSS)</status>
				</microsatellite_instability>
				<tumor_mutation_burden>
					<score>1.9 muts/Mb</score>
				</tumor_mutation_burden>
			</biomarkers>
		</variant-report>
	</rr:ResultsPayload>
</rr:ResultsReport>